[Modification by practolol (ICI50-172) of respiratory function, arterial blood gases and hemodynamics in healthy subjects and in patients with obstructive respiratory tract disease].
D000083:Acetanilides / Q000494:pharmacology / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000403:Airway Resistance / Q000187:drug effects; D001249:Asthma / Q000188:drug therapy*; D001980:Bronchi / Q000187:drug effects; D001991:Bronchitis / Q000188:drug therapy; D002245:Carbon Dioxide / Q000097:blood; D004562:Electrocardiography; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008875:Middle Aged; D009130:Muscle, Smooth / Q000187:drug effects; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D012123:Pulmonary Ventilation / Q000187:drug effects; D012137:Respiratory System / Q000187:drug effects*; D013565:Sympatholytics / Q000494:pharmacology* / Q000627:therapeutic use; D014797:Vital Capacity
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D002245:Carbon Dioxide; D010100:Oxygen
Der Einfluss von Practolol (ICI50-172) auf Atemfunktionsgrössen, arterielle Blutgase und Hämodynamik bei Gesunden und Patienten mit obstruktiven Atemwegserkrankungen.